Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Arctigenin Attenuates Hepatic Ischemia/Reperfusion Injury by Enhancing NRF2-GST/GPX4 Antioxidant Response

  1. 1School of Food and Biological Engineering, Xuzhou University of Technology, Xuzhou 221018, China
  2. 2Jiangsu Key Laboratory of Food Resource Development and Quality Safe, Xuzhou University of Technology, Xuzhou 221018, China
  3. 3School of Bioengineering, Jiangnan University, Wuxi 214122, China

Abstract

Hepatic ischemia/reperfusion injury (IRI) remains a major cause of graft dysfunction and postoperative liver failure, and no specific pharmacological therapy is available. Oxidative stress plays a key role in hepatic IRI, making arctigenin (AG), a compound with antioxidant and anti-inflammatory activities, a potential therapeutic candidate. We evaluated AG using a 70% hepatic ischemia/reperfusion model in male C57BL/6 mice and cellular injury models induced by hypoxia/reoxygenation (H/R) or H2O2 exposure in AML12 cells. AG dose-dependently attenuated hepatic injury, reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and decreased hepatic necrosis. AG also reduced inflammatory macrophage abundance and pro-inflammatory cytokine expression in the liver after IRI. In AML12 cells, AG improved viability and reduced ROS accumulation and lipid peroxidation. Transcriptomic analysis identified glutathione metabolism, glutathione transferase activity, and cellular detoxification as major AG-responsive processes. AG promoted nuclear accumulation of nuclear factor erythroid 2-related factor 2 (NRF2), increased the expression of multiple glutathione S-transferases (GSTs) and glutathione peroxidase 4 (GPX4), and enhanced GST and GSH-Px activities. Pharmacological inhibition of NRF2, GPX4, or GSTs attenuated AG-mediated cytoprotection. NRF2 knockdown also weakened AG-associated improvements in cell viability, apoptosis, ROS levels, and antioxidant enzyme activities after H/R. In mice, ML385 attenuated AG-associated antioxidant responses and hepatoprotection. These findings support a role for NRF2 in AG-mediated protection and implicate GST- and GPX4-associated antioxidant defenses in its effects against hepatic IRI.

Related

  1. From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury
    Heng Zhao, Zhe Chen, Chi Wang +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis
    Xiaobing Shi, Man Wang, Xiaowei Zhou +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. PRMT1 facilitates the renal ischemia-reperfusion injury by inducing the ferroptosis via mediating the arginine methylation of ACSL4
    Yanhan Lin, Bocheng Zhu, Xiaofeng Zhu +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  4. Renoprotective Effects of Vortioxetine in Experimental Renal Ischemia–Reperfusion Injury: An Investigation of Oxidative Stress, Inflammation, and Apoptotic Signaling
    Resul Çiçek, İbrahim Topçu, Bulut Dural +4
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. Dynamic regulation of cystathionine gamma-lyase expression during normoxia, ischemia, and reperfusion in liver: interplay of transcription factors, microRNAs, and histone modifications
    N. R. Mahapatra, A. K. Patel, N. Ganesh +4
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
BibTeX
@article{wang2026arctigenin,
  title = {{Arctigenin Attenuates Hepatic Ischemia/Reperfusion Injury by Enhancing NRF2-GST/GPX4 Antioxidant Response}},
  author = {Zhe Wang and Ruishuo Liang and Mingshun Xu and Ying Shao and Lulu Li and Zaizhong Ni and Yanan Wang and Anhui Chen},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210109},
  url = {https://www.mdpi.com/1422-0067/27/22/10109},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Arctigenin Attenuates Hepatic Ischemia/Reperfusion Injury by Enhancing NRF2-GST/GPX4 Antioxidant Response
AU  - Zhe Wang
AU  - Ruishuo Liang
AU  - Mingshun Xu
AU  - Ying Shao
AU  - Lulu Li
AU  - Zaizhong Ni
AU  - Yanan Wang
AU  - Anhui Chen
PY  - 2026
DA  - 2026/11/11
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210109
UR  - https://www.mdpi.com/1422-0067/27/22/10109
AB  - Hepatic ischemia/reperfusion injury (IRI) remains a major cause of graft dysfunction and postoperative liver failure, and no specific pharmacological therapy is available. Oxidative stress plays a key role in hepatic IRI, making arctigenin (AG), a compound with antioxidant and anti-inflammatory activities, a potential therapeutic candidate. We evaluated AG using a 70% hepatic ischemia/reperfusion model in male C57BL/6 mice and cellular injury models induced by hypoxia/reoxygenation (H/R) or H2O2 exposure in AML12 cells. AG dose-dependently attenuated hepatic injury, reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and decreased hepatic necrosis. AG also reduced inflammatory macrophage abundance and pro-inflammatory cytokine expression in the liver after IRI. In AML12 cells, AG improved viability and reduced ROS accumulation and lipid peroxidation. Transcriptomic analysis identified glutathione metabolism, glutathione transferase activity, and cellular detoxification as major AG-responsive processes. AG promoted nuclear accumulation of nuclear factor erythroid 2-related factor 2 (NRF2), increased the expression of multiple glutathione S-transferases (GSTs) and glutathione peroxidase 4 (GPX4), and enhanced GST and GSH-Px activities. Pharmacological inhibition of NRF2, GPX4, or GSTs attenuated AG-mediated cytoprotection. NRF2 knockdown also weakened AG-associated improvements in cell viability, apoptosis, ROS levels, and antioxidant enzyme activities after H/R. In mice, ML385 attenuated AG-associated antioxidant responses and hepatoprotection. These findings support a role for NRF2 in AG-mediated protection and implicate GST- and GPX4-associated antioxidant defenses in its effects against hepatic IRI.
SN  - 1422-0067
ER  -